David Logue sees the industry adapting to address medical needs and deliver treatments to patients in ways that afford greater personal empowerment.
David Logue
Advertisement
David Logue is a managing director in Accenture's Life Sciences practice, based in London, UK.
Articles by David Logue
By the end of 2020, it is predicted that AI will create more jobs than it is taking. Should reps be concerned, asks David Logue.
Advertisement
Latest Updated Articles
Will AI Kill Pharma Rep Jobs?Published: August 5th 2019 | Updated:
Patients' Role in Healthcare Decisions Will Transform Industry’s Model of CarePublished: February 4th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
